MannKind Corp (MNKD)
4.275
+0.10
(+2.27%)
USD |
NASDAQ |
Apr 26, 15:01
MannKind Revenue (TTM): 198.96M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 198.96M |
| September 30, 2023 | 176.55M |
| June 30, 2023 | 158.12M |
| March 31, 2023 | 128.40M |
| December 31, 2022 | 99.77M |
| September 30, 2022 | 76.23M |
| June 30, 2022 | 65.61M |
| March 31, 2022 | 70.00M |
| December 31, 2021 | 75.44M |
| September 30, 2021 | 81.37M |
| June 30, 2021 | 74.51M |
| March 31, 2021 | 66.34M |
| December 31, 2020 | 65.14M |
| September 30, 2020 | 62.69M |
| Date | Value |
|---|---|
| June 30, 2020 | 61.94M |
| March 31, 2020 | 61.82M |
| December 31, 2019 | 63.04M |
| September 30, 2019 | 63.08M |
| June 30, 2019 | 52.95M |
| March 31, 2019 | 41.84M |
| December 31, 2018 | 27.86M |
| September 30, 2018 | 16.36M |
| June 30, 2018 | 13.93M |
| March 31, 2018 | 12.20M |
| December 31, 2017 | 11.74M |
| September 30, 2017 | 19.62M |
| June 30, 2017 | 179.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
52.95M
Minimum
Jun 2019
198.96M
Maximum
Dec 2023
89.58M
Average
70.00M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Cassava Sciences Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |